Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Preventive use of gabapentin to decrease pain and systemic symptoms in patients with head and neck cancer undergoing chemoradiation
Derek K. Smith, Anthony J. Cmelak, K.J. Niermann, et al.
Head & Neck (2020) Vol. 42, Iss. 12, pp. 3497-3505
Closed Access | Times Cited: 32

Showing 1-25 of 32 citing articles:

Expert Consensus Statement: Management of Dysphagia in Head and Neck Cancer Patients
Maggie A. Kuhn, M. Boyd Gillespie, Stacey L. Ishman, et al.
Otolaryngology (2023) Vol. 168, Iss. 4, pp. 571-592
Open Access | Times Cited: 29
Severe Oral Mucositis After Intensity-Modulated Radiation Therapy for Head and Neck Cancer
Austin J. Iovoli, Lauren Turecki, Michelle L. Qiu, et al.
JAMA Network Open (2023) Vol. 6, Iss. 10, pp. e2337265-e2337265
Open Access | Times Cited: 24
Emerging pharmacotherapy trends in preventing and managing oral mucositis induced by chemoradiotherapy and targeted agents
Margherita Gobbo, Jamie K. Joy, Helena Guedes, et al.
Expert Opinion on Pharmacotherapy (2024) Vol. 25, Iss. 6, pp. 727-742
Closed Access | Times Cited: 4
Perioperative Pain Management in Patients With Cancer-Related Pain: A Narrative Review
Storm Horine, Neal Rakesh, Danielle Nadav, et al.
Anesthesia & Analgesia (2025)
Closed Access
Efficacy of prophylactic gabapentin in managing oral mucositis pain in patients undergoing non-surgical management of head and neck tumors
Virda Baig, Syed Fasih Ahmed Hashmi, Maryam Altuhafy, et al.
Supportive Care in Cancer (2025) Vol. 33, Iss. 3
Closed Access
Opioid therapy vs. Multimodal analgesia in head and neck cancer (OPTIMAL-HN): Results of a randomized clinical trial
Sondos Zayed, Pencilla Lang, Nancy Read, et al.
Radiotherapy and Oncology (2025), pp. 110831-110831
Closed Access
Pharmacological Management of Neuropathic Pain after Radiotherapy in Head and Neck Cancer Patients: A Systematic Review
Maria Kouri, Martina Rekatsina, Athina Vadalouca, et al.
Journal of Clinical Medicine (2022) Vol. 11, Iss. 16, pp. 4877-4877
Open Access | Times Cited: 15
Randomized Phase 3, Double-Blind, Placebo-Controlled Study of Prophylactic Gabapentin for the Reduction of Oral Mucositis Pain During the Treatment of Oropharyngeal Squamous Cell Carcinoma
Andrew Cook, Ankit Modh, Haythem Ali, et al.
International Journal of Radiation Oncology*Biology*Physics (2021) Vol. 112, Iss. 4, pp. 926-937
Closed Access | Times Cited: 17
Gabapentinoids for chemotherapy-induced peripheral neuropathy: systematic review and meta-analysis
T. Chang, Fuyu Yang, Yu‐Chang Liu, et al.
BMJ Supportive & Palliative Care (2024) Vol. 14, Iss. 3, pp. 269-278
Closed Access | Times Cited: 2
Association of Gabapentin Use With Pain Control and Feeding Tube Placement Among Patients With Head and Neck Cancer Receiving Chemoradiotherapy
Sung Jun, Katy Wang, Austin J. Iovoli, et al.
JAMA Network Open (2022) Vol. 5, Iss. 5, pp. e2212900-e2212900
Open Access | Times Cited: 8
Efficacy of Prophylactic High-Dose Gabapentin and Venlafaxine on Reducing Oral Mucositis Pain Among Patients Treated With Chemoradiation for Head and Neck Cancer: A Single-Institution, Phase 2, Randomized Clinical Trial
Sung Jun, Austin J. Iovoli, Katy Wang, et al.
International Journal of Radiation Oncology*Biology*Physics (2023) Vol. 116, Iss. 4, pp. 797-806
Closed Access | Times Cited: 4
Systemic Anti-Inflammatory Agents in the Prevention of Chemoradiation-Induced Mucositis: A Review of Randomised Controlled Trials
Ali Ibrahim Mohammed, Lexi Fedoruk, Nicholas M. Fisher, et al.
Biomolecules (2024) Vol. 14, Iss. 5, pp. 560-560
Open Access | Times Cited: 1
Painful Realities: Navigating the Complexities of Head and Neck Cancer Pain
Hayden F. Byrd, Zachary A. Kohutek
Oral Diseases (2024)
Open Access | Times Cited: 1
Pregabalin for Neuropathic Pain in Post-radiotherapy Head and Neck Cancer Patients: A Retrospective Study and Review of the Literature
Maria Kouri, Erofili Papadopoulou, Emmanouil Vardas, et al.
Cureus (2024)
Open Access | Times Cited: 1
Mechanisms of pain and their manifestations in head and neck cancer: Importance of classifying pain subtypes
Dianne I. Lou, Mary S. Dietrich, Jie Deng, et al.
Head & Neck (2021) Vol. 43, Iss. 12, pp. 3720-3729
Open Access | Times Cited: 10
Facial pain, health-related quality of life and trismus-related symptoms up to 5 years post-radiotherapy for head and neck cancer
Susan Aghajanzadeh, Therese Karlsson, Lisa Tuomi, et al.
Supportive Care in Cancer (2023) Vol. 31, Iss. 12
Open Access | Times Cited: 3
Overcoming Barriers to Radiation Oncology Access in Low-Resource Settings in the United States
Malcolm D. Mattes, Gita Suneja, Bruce G. Haffty, et al.
Advances in Radiation Oncology (2021) Vol. 6, Iss. 6, pp. 100802-100802
Open Access | Times Cited: 7
Geographic Variation in the Use of Gabapentinoids and Opioids for Pain in a Commercially Insured Adult Population in the United States
Danni Zhao, Jonggyu Baek, Anne L. Hume, et al.
Journal of Pain Research (2022) Vol. Volume 15, pp. 443-454
Open Access | Times Cited: 4
Opioid Therapy vs. Multimodal Analgesia in Head and Neck Cancer (Optimal-Hn): Results of a Randomized Clinical Trial
Sondos Zayed, Pencilla Lang, Nancy Read, et al.
(2024)
Closed Access
Prophylactic gabapentin during head and neck cancer therapy: a systematic review and meta-analysis
Loren E. Smith, Barbara A. Murphy, Derek K. Smith
Supportive Care in Cancer (2023) Vol. 31, Iss. 4
Open Access | Times Cited: 1
Prophylactic High-Dose Gabapentin Reduces Opiate Use during Radiation Therapy for Head and Neck Squamous Cell Carcinoma
Michelle L. Qiu, Austin J. Iovoli, Michael Khan, et al.
Cancers (2023) Vol. 15, Iss. 7, pp. 2003-2003
Open Access | Times Cited: 1
Evaluation of Gabapentin as a Treatment of Breakthrough Cancer Pain Caused by Metastatic Prostate Adenocarcinoma
Jufriady Ismy, Dessy Rakhmawati Emril, Said Alfin Khalilullah, et al.
Journal of Pain Research (2023) Vol. Volume 16, pp. 3319-3324
Open Access | Times Cited: 1
In Regard to Cook et al.
Derek K. Smith, Barbara A. Murphy
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 113, Iss. 5, pp. 1103-1104
Closed Access | Times Cited: 2
The Burning Question: Prophylactic Gabapentin for Mucositis-Related Pain in Patients Undergoing Chemoradiation Therapy for Head and Neck Cancer?
Lachlan McDowell, Paolo Bossi
International Journal of Radiation Oncology*Biology*Physics (2022) Vol. 112, Iss. 4, pp. 938-941
Open Access | Times Cited: 1
Effectiveness of gabapentin in reducing opioid requirements after radiation in head and neck cancer in a single institution
David R. Gilley, Andrew Clark, Maggie E. Wieser, et al.
Head & Neck (2022) Vol. 44, Iss. 6, pp. 1368-1376
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top